{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T15:21:43Z","timestamp":1778340103215,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009727","name":"Hospital Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009727","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008810","name":"New South Wales Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008810","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025520","name":"Medical Research Future Fund","doi-asserted-by":"publisher","award":["APP1200005"],"award-info":[{"award-number":["APP1200005"]}],"id":[{"id":"10.13039\/501100025520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1086386"],"award-info":[{"award-number":["APP1086386"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1137563"],"award-info":[{"award-number":["APP1137563"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP2006883"],"award-info":[{"award-number":["APP2006883"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015069","name":"South Eastern Sydney Local Health District","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jacl.2025.08.006","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T22:57:35Z","timestamp":1754521055000},"page":"1439-1450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["HDL remodeling and enrichment with apoCIII and apoE in Indigenous Australians"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0848-5930","authenticated-orcid":false,"given":"Maaike","family":"Kockx","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3169-729X","authenticated-orcid":false,"given":"Jeffrey","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha J.","family":"Howard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avinash","family":"Suryawanshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Nicholls","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5818-8024","authenticated-orcid":false,"given":"Leonard","family":"Kritharides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9683","key":"10.1016\/j.jacl.2025.08.006_bib0001","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0140-6736(09)60914-4","article-title":"Indigenous health part 1: determinants and disease patterns","volume":"374","author":"Gracey","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jacl.2025.08.006_bib0002","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5694\/mja17.00897","article-title":"Absolute cardiovascular disease risk and lipid-lowering therapy among Aboriginal and Torres Strait Islander Australians","volume":"209","author":"Calabria","year":"2018","journal-title":"Med J Aust"},{"key":"10.1016\/j.jacl.2025.08.006_bib0003","series-title":"Health and Torres Strait Islander Health Performance Framework Summary Report","year":"2020"},{"issue":"2","key":"10.1016\/j.jacl.2025.08.006_bib0004","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.atherosclerosis.2008.03.022","article-title":"Australian aboriginal people and Torres Strait Islanders have an atherogenic lipid profile that is characterised by low HDL-cholesterol level and small LDL particles","volume":"201","author":"O\u2019Neal","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2025.08.006_bib0005","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1186\/1471-2458-14-545","article-title":"Evidence for low high-density lipoprotein cholesterol levels in Australian indigenous peoples: a systematic review","volume":"14","author":"Lyons","year":"2014","journal-title":"BMC Public Health"},{"issue":"5","key":"10.1016\/j.jacl.2025.08.006_bib0006","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0002-9343(77)90874-9","article-title":"High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study","volume":"62","author":"Gordon","year":"1977","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.jacl.2025.08.006_bib0007","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrcardio.2017.115","article-title":"HDL and atherosclerotic cardiovascular disease: genetic insights into complex biology","volume":"15","author":"Rosenson","year":"2018","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"10.1016\/j.jacl.2025.08.006_bib0008","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/CIRCRESAHA.117.311978","article-title":"Trials and tribulations of CETP inhibitors","volume":"122","author":"Tall","year":"2018","journal-title":"Circ Res"},{"issue":"32","key":"10.1016\/j.jacl.2025.08.006_bib0009","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1093\/eurheartj\/ehx163","article-title":"Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies","volume":"38","author":"Madsen","year":"2017","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jacl.2025.08.006_bib0010","doi-asserted-by":"crossref","DOI":"10.1172\/JCI148559","article-title":"Addressing dyslipidemic risk beyond LDL-cholesterol","volume":"132","author":"Tall","year":"2022","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.jacl.2025.08.006_bib0011","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1194\/jlr.M042333","article-title":"Obesity favors apolipoprotein E- and C-III-containing high density lipoprotein subfractions associated with risk of heart disease","volume":"55","author":"Talayero","year":"2014","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.jacl.2025.08.006_bib0012","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1038\/s41598-017-02601-7","article-title":"ApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacity","volume":"7","author":"Luo","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.jacl.2025.08.006_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.98045","article-title":"Apolipoproteins E and CIII interact to regulate HDL metabolism and coronary heart disease risk","volume":"3","author":"Morton","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.jacl.2025.08.006_bib0014","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.atherosclerosis.2017.12.029","article-title":"High density lipoprotein with apolipoprotein C-III is associated with carotid intima-media thickness among generally healthy individuals","volume":"269","author":"Yamamoto","year":"2018","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.jacl.2025.08.006_bib0015","doi-asserted-by":"crossref","first-page":"84","DOI":"10.7326\/0003-4819-150-2-200901200-00006","article-title":"High-density lipoprotein particle size and concentration and coronary risk","volume":"150","author":"El Harchaoui","year":"2009","journal-title":"Ann Intern Med"},{"issue":"35","key":"10.1016\/j.jacl.2025.08.006_bib0016","doi-asserted-by":"crossref","first-page":"24020","DOI":"10.1074\/jbc.R114.583658","article-title":"Molecular mechanisms of cellular cholesterol efflux","volume":"289","author":"Phillips","year":"2014","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.jacl.2025.08.006_bib0017","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1161\/CIRCRESAHA.116.305485","article-title":"HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export","volume":"116","author":"Du","year":"2015","journal-title":"Circ Res"},{"issue":"15","key":"10.1016\/j.jacl.2025.08.006_bib0018","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1161\/CIRCULATIONAHA.111.066589","article-title":"Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport","volume":"125","author":"Rosenson","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2025.08.006_bib0019","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.774418","article-title":"Cholesterol efflux capacity and its association with adverse cardiovascular events: a systematic review and meta-analysis","volume":"8","author":"Lee","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.jacl.2025.08.006_bib0020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12944-022-01657-3","article-title":"High-density lipoprotein cholesterol efflux capacity and incidence of coronary artery disease and cardiovascular mortality: a systematic review and meta-analysis","volume":"21","author":"Cheng","year":"2022","journal-title":"Lipids Health Dis"},{"issue":"5","key":"10.1016\/j.jacl.2025.08.006_bib0021","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.metabol.2014.03.001","article-title":"Enhanced cholesterol efflux to HDL through the ABCA1 transporter in hypertriglyceridemia of type 2 diabetes","volume":"63","author":"Yassine","year":"2014","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.jacl.2025.08.006_bib0022","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.atherosclerosis.2015.07.019","article-title":"Increased cholesterol efflux capacity in metabolic syndrome: relation with qualitative alterations in HDL and LCAT","volume":"242","author":"Lucero","year":"2015","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.jacl.2025.08.006_bib0023","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jacc.2018.05.043","article-title":"Impaired renal function on cholesterol efflux capacity, HDL particle number, and cardiovascular events","volume":"72","author":"Chindhy","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"10.1016\/j.jacl.2025.08.006_bib0024","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1056\/NEJMoa2400969","article-title":"Apolipoprotein A1 infusions and cardiovascular outcomes after acute myocardial infarction","volume":"390","author":"Gibson","year":"2024","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jacl.2025.08.006_bib0025","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1161\/ATVBAHA.120.314847","article-title":"Increased ABCA1 (ATP-Binding Cassette Transporter A1)-specific cholesterol efflux capacity in schizophrenia","volume":"40","author":"Luquain-Costaz","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"25","key":"10.1016\/j.jacl.2025.08.006_bib0026","doi-asserted-by":"crossref","first-page":"25966","DOI":"10.1074\/jbc.M401177200","article-title":"Apolipoprotein A-I-stimulated apolipoprotein E secretion from human macrophages is independent of cholesterol efflux","volume":"279","author":"Kockx","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacl.2025.08.006_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101261","article-title":"Calorie restriction improves lipid-related emerging cardiometabolic risk factors in healthy adults without obesity: distinct influences of BMI and sex from CALERIE a multicentre, phase 2, randomised controlled trial","volume":"43","author":"Huffman","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jacl.2025.08.006_bib0028","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.athplu.2022.01.003","article-title":"Effects of pre-eclampsia on HDL-mediated cholesterol effiux capacity after pregnancy","volume":"48","author":"Kockx","year":"2022","journal-title":"Atherosclerosis Plus"},{"issue":"1","key":"10.1016\/j.jacl.2025.08.006_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.131491","article-title":"Structure-function relationships of HDL in diabetes and coronary heart disease","volume":"5","author":"Cardner","year":"2020","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.jacl.2025.08.006_bib0030","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3390\/biomedicines9030242","article-title":"Obesity affects HDL metabolism, composition and subclass distribution","volume":"9","author":"Stadler","year":"2021","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.jacl.2025.08.006_bib0031","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1161\/CIRCRESAHA.120.317178","article-title":"Diabetes impairs cellular cholesterol efflux from ABCA1 to small HDL particles","volume":"127","author":"He","year":"2020","journal-title":"Circ Res"},{"issue":"25","key":"10.1016\/j.jacl.2025.08.006_bib0032","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1161\/CIRCULATIONAHA.116.025678","article-title":"Cholesterol efflux capacity, high-density lipoprotein particle number, and incident cardiovascular events: an analysis from the JUPITER trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin)","volume":"135","author":"Khera","year":"2017","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.jacl.2025.08.006_bib0033","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/CIRCULATIONAHA.120.045713","article-title":"Associations between high-density lipoprotein particles and ischemic events by vascular domain, sex, and ethnicity: a pooled cohort analysis","volume":"142","author":"Singh","year":"2020","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.jacl.2025.08.006_bib0034","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1161\/01.ATV.0000022015.97341.3A","article-title":"Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the cardiovascular health study","volume":"22","author":"Kuller","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"10.1016\/j.jacl.2025.08.006_bib0035","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.molmed.2011.05.013","article-title":"Biological activities of HDL subpopulations and their relevance to cardiovascular disease","volume":"17","author":"Camont","year":"2011","journal-title":"Trends Mol Med"},{"issue":"13","key":"10.1016\/j.jacl.2025.08.006_bib0036","doi-asserted-by":"crossref","first-page":"12448","DOI":"10.1074\/jbc.M311718200","article-title":"Scavenger receptor class B type I-mediated cholesteryl ester-selective uptake and efflux of unesterified cholesterol. Influence of high density lipoprotein size and structure","volume":"279","author":"Thuahnai","year":"2004","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.jacl.2025.08.006_bib0037","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/ATVBAHA.121.317181","article-title":"Pharmacological inhibition of CETP (Cholesteryl Ester Transfer Protein) increases HDL (High-Density Lipoprotein) that contains ApoC3 and other HDL subspecies associated with higher risk of coronary heart disease","volume":"42","author":"Furtado","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"10.1016\/j.jacl.2025.08.006_bib0038","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/CIRCULATIONAHA.112.108753","article-title":"Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling","volume":"127","author":"Riwanto","year":"2013","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.jacl.2025.08.006_bib0039","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1161\/ATVBAHA.120.314609","article-title":"Protein-defined subspecies of HDLs (High-Density Lipoproteins) and differential risk of coronary heart disease in 4 prospective studies","volume":"40","author":"Sacks","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.jacl.2025.08.006_bib0040","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1194\/jlr.M063701","article-title":"Proteomic analysis of HDL from inbred mouse strains implicates APOE associated with HDL in reduced cholesterol efflux capacity via the ABCA1 pathway","volume":"57","author":"Pamir","year":"2016","journal-title":"J Lipid Res"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287425003587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287425003587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:09:57Z","timestamp":1766156997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287425003587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1933287425003587"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2025.08.006","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HDL remodeling and enrichment with apoCIII and apoE in Indigenous Australians","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2025.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of National Lipid Association.","name":"copyright","label":"Copyright"}]}}